openPR Logo
Press release

Rosacea Therapeutics Market To Ride On Data-Driven Innovation Intelligence At A CAGR Of 6.2%

07-04-2022 11:00 PM CET | Health & Medicine

Press release from: Persistence Market Research

Rosacea Therapeutics Market To Ride On Data-Driven Innovation

As per Persistence Market Research's latest industry analysis, expanding at a CAGR of 6.2%, the global rosacea therapeutics market is projected to increase from a valuation of US$ 3.94 Bn in 2021 to US$ 7.61 Bn by 2032.

Rosacea is a common skin condition characterized by raised blood vessels and redness on the face, where the nose and cheeks are the most affected areas. The signs and symptoms of rosacea are small red pus-filled bumps that may burst periodically. Around half of the patients experience dry irritated eyes and swollen red eyelids. Other symptoms include an enlarged nose and thickened nasal skin (rhinoplasty). Rosacea mainly affects middle-aged women with fair skin.

According to the National Rosacea Association, rosacea affects around 15 million people worldwide. Prevalence of rosacea in the general population is estimated at 2.5% to 5.5%.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/18793

Lack of curative treatment for rosacea has resulted in the emphasis on symptomatic treatment to control or eliminate its various signs and symptoms. Growing out-of-pocket expenditure is another driver for the market owing to the rising emphasis on personal health.

Key rosacea therapeutic service providers are focusing on market expansion through collaborations and acquisitions. They are promoting their products at professional scientific meetings and conferences. This promotional strategy will be very impactful to penetrate the market. Sales representatives of companies directly contact professionals and physically present their product offerings, thus expanding their company's presence into different geographies.

An example is, in Feb 2022, Novartis experienced mid-single digit sales growth, margin expansion, and advancement of its robust pipeline.

Company Profiles:

Lupin Ltd
Dr. Reddy's Laboratories Ltd
VIATRIS (Mylan N.V.)
Ajanta Pharma Ltd
Cipla Ltd
Gary Pharmaceuticals P Limited
Glenmark Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Mission Pharmacal
Sanofi SA
VYNE Therapeutics
Galderma
Bayer AG
Bausch Health Companies Inc.
Hovione
PruGen Pharmaceuticals
AbbVie, Inc.
Eckson Labs
Sandoz Spa
Abigail Care Pharmaceutical
Pfizer Inc.
Johnson & Johnson (Janssen Pharmaceuticals, Inc.)

Request for Methodology @ https://www.persistencemarketresearch.com/methodology/18793

Key Takeaways from Market Study

Erythematotelangiectatic rosacea, a subtype of rosacea, which is characterised by recurrent episodes of transient face erythema (flushing) and no transient, or chronic, erythema, occurs most commonly amongst and holds the highest market share of around 35.4%.

Antibiotics are the most commonly preferred drug class by physicians for early relief from the disease. This segment accounts for the highest share of 39.5% in the market.

Treatment of rosacea is challenging given the varied manifestations and incompletely understood etiology. Topical treatment is growing tremendously and holds a market share of 29.3%.

Pharmaceutical companies are steadily transitioning toward innovation and sales of new drugs. Thus, retail sales, including retail pharmacies & drug stores hold the highest market share of 52.1%.

The North America rosacea therapeutics market accounted for 32.6% of the total market share, by value, in 2021.

"Increased prevalence of rosacea and advances in patient-specific pathophysiology will drive the rosacea therapeutics market over the coming years," says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/18793

Market Competition

Key providers of rosacea therapeutics are investing in innovating cost-effective treatment to gain the attention of healthcare providers. Along with product innovation, key players are also aiming for various acquisitions to create goodwill and successfully market their products.

For instance, on December 1, 2021, Sanofi entered into an agreement to acquire Origimm Biotechnology GmbH.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the rosacea therapeutics market in its latest study, presenting historical demand assessment of 2017 - 2021 and projections for 2022 - 2032.

Access PMR Exclusive Reports-

Testing Inspection And Certification Market- https://www.persistencemarketresearch.com/market-research/testing-inspection-and-certification-market.asp

8K Technology Market- https://www.persistencemarketresearch.com/market-research/8k-technology-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rosacea Therapeutics Market To Ride On Data-Driven Innovation Intelligence At A CAGR Of 6.2% here

News-ID: 2670977 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the